vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Piedmont Realty Trust, Inc.（PDM）财务数据对比。点击上方公司名可切换其他公司
Piedmont Realty Trust, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.9倍（$142.9M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -0.3%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -0.6%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Piedmont Realty Trust是一家公开上市的房地产投资信托（REIT），主要持有、运营和投资美国高增长大都会区的优质写字楼资产，服务科技、专业服务、医疗等多个行业的企业租户，通过战略资产管理和投资组合优化为利益相关方提供稳定长期回报。
PBYI vs PDM — 直观对比
营收规模更大
PDM
是对方的1.9倍
$75.5M
营收增速更快
PBYI
高出28.0%
-0.3%
两年增速更快
PBYI
近两年复合增速
-0.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $142.9M |
| 净利润 | — | $-43.2M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | — |
| 净利率 | — | -30.3% |
| 营收同比 | 27.7% | -0.3% |
| 净利润同比 | — | -44.3% |
| 每股收益（稀释后） | $0.26 | $-0.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIPDM
| Q4 25 | $75.5M | $142.9M | ||
| Q3 25 | $54.5M | $139.2M | ||
| Q2 25 | $52.4M | $140.3M | ||
| Q1 25 | $46.0M | $142.7M | ||
| Q4 24 | $59.1M | $143.2M | ||
| Q3 24 | $80.5M | $139.3M | ||
| Q2 24 | $47.1M | $143.3M | ||
| Q1 24 | $43.8M | $144.5M |
净利润PBYIPDM
| Q4 25 | — | $-43.2M | ||
| Q3 25 | $8.8M | $-13.5M | ||
| Q2 25 | $5.9M | $-16.8M | ||
| Q1 25 | $3.0M | $-10.1M | ||
| Q4 24 | — | $-30.0M | ||
| Q3 24 | $20.3M | $-11.5M | ||
| Q2 24 | $-4.5M | $-9.8M | ||
| Q1 24 | $-4.8M | $-27.8M |
毛利率PBYIPDM
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率PBYIPDM
| Q4 25 | 22.7% | — | ||
| Q3 25 | 17.6% | — | ||
| Q2 25 | 12.7% | — | ||
| Q1 25 | 8.7% | — | ||
| Q4 24 | 22.6% | — | ||
| Q3 24 | 27.4% | — | ||
| Q2 24 | -4.6% | — | ||
| Q1 24 | -5.3% | — |
净利率PBYIPDM
| Q4 25 | — | -30.3% | ||
| Q3 25 | 16.2% | -9.7% | ||
| Q2 25 | 11.2% | -12.0% | ||
| Q1 25 | 6.5% | -7.1% | ||
| Q4 24 | — | -20.9% | ||
| Q3 24 | 25.2% | -8.3% | ||
| Q2 24 | -9.6% | -6.8% | ||
| Q1 24 | -11.0% | -19.2% |
每股收益（稀释后）PBYIPDM
| Q4 25 | $0.26 | $-0.34 | ||
| Q3 25 | $0.17 | $-0.11 | ||
| Q2 25 | $0.12 | $-0.14 | ||
| Q1 25 | $0.06 | $-0.08 | ||
| Q4 24 | $0.40 | $-0.25 | ||
| Q3 24 | $0.41 | $-0.09 | ||
| Q2 24 | $-0.09 | $-0.08 | ||
| Q1 24 | $-0.10 | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $731.0K |
| 总债务越低越好 | $22.7M | $2.2B |
| 股东权益账面价值 | $130.3M | $1.5B |
| 总资产 | $216.3M | $4.0B |
| 负债/权益比越低杠杆越低 | 0.17× | 1.49× |
8季度趋势，按日历期对齐
现金及短期投资PBYIPDM
| Q4 25 | $97.5M | $731.0K | ||
| Q3 25 | $94.4M | $3.0M | ||
| Q2 25 | $96.0M | $3.3M | ||
| Q1 25 | $93.2M | $2.9M | ||
| Q4 24 | $101.0M | $109.6M | ||
| Q3 24 | $96.7M | $133.6M | ||
| Q2 24 | $96.8M | $138.5M | ||
| Q1 24 | $107.2M | $3.5M |
总债务PBYIPDM
| Q4 25 | $22.7M | $2.2B | ||
| Q3 25 | $34.0M | $2.2B | ||
| Q2 25 | $45.3M | $2.2B | ||
| Q1 25 | $56.7M | $2.2B | ||
| Q4 24 | $68.0M | $2.2B | ||
| Q3 24 | $79.3M | $2.2B | ||
| Q2 24 | $90.7M | $2.2B | ||
| Q1 24 | $102.0M | $2.1B |
股东权益PBYIPDM
| Q4 25 | $130.3M | $1.5B | ||
| Q3 25 | $115.3M | $1.5B | ||
| Q2 25 | $104.7M | $1.5B | ||
| Q1 25 | $97.1M | $1.6B | ||
| Q4 24 | $92.1M | $1.6B | ||
| Q3 24 | $71.1M | $1.6B | ||
| Q2 24 | $48.5M | $1.7B | ||
| Q1 24 | $51.0M | $1.7B |
总资产PBYIPDM
| Q4 25 | $216.3M | $4.0B | ||
| Q3 25 | $202.9M | $4.0B | ||
| Q2 25 | $194.9M | $4.0B | ||
| Q1 25 | $196.2M | $4.0B | ||
| Q4 24 | $213.3M | $4.1B | ||
| Q3 24 | $220.7M | $4.1B | ||
| Q2 24 | $205.0M | $4.2B | ||
| Q1 24 | $214.1M | $4.0B |
负债/权益比PBYIPDM
| Q4 25 | 0.17× | 1.49× | ||
| Q3 25 | 0.30× | 1.43× | ||
| Q2 25 | 0.43× | 1.41× | ||
| Q1 25 | 0.58× | 1.40× | ||
| Q4 24 | 0.74× | 1.40× | ||
| Q3 24 | 1.12× | 1.36× | ||
| Q2 24 | 1.87× | 1.34× | ||
| Q1 24 | 2.00× | 1.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $140.6M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | — |
| 自由现金流率自由现金流/营收 | 19.1% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势，按日历期对齐
经营现金流PBYIPDM
| Q4 25 | $14.4M | $140.6M | ||
| Q3 25 | $9.7M | $35.8M | ||
| Q2 25 | $14.1M | $50.1M | ||
| Q1 25 | $3.6M | $3.7M | ||
| Q4 24 | $15.6M | $198.1M | ||
| Q3 24 | $11.0M | $42.9M | ||
| Q2 24 | $1.0M | $66.8M | ||
| Q1 24 | $11.2M | $23.4M |
自由现金流PBYIPDM
| Q4 25 | $14.4M | — | ||
| Q3 25 | $9.7M | — | ||
| Q2 25 | $14.1M | — | ||
| Q1 25 | $3.6M | — | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $1.0M | — | ||
| Q1 24 | — | — |
自由现金流率PBYIPDM
| Q4 25 | 19.1% | — | ||
| Q3 25 | 17.7% | — | ||
| Q2 25 | 26.8% | — | ||
| Q1 25 | 7.7% | — | ||
| Q4 24 | 26.4% | — | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | — | — |
资本支出强度PBYIPDM
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率PBYIPDM
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
PDM
| Atlanta GA | $45.7M | 32% |
| Dallas TX | $24.1M | 17% |
| Orlando FL | $19.3M | 13% |
| New York NY | $14.7M | 10% |
| Northern Virginia Washington D.C. | $12.9M | 9% |
| Minneapolis MN | $11.4M | 8% |
| Boston MA | $9.8M | 7% |
| Real Estate Other | $7.8M | 5% |
